Clinical trial • Phase I/II • Gastroenterology
Clinical trial in Liver transplant | Ischemia-reperfusion injury
Phase I/II trial for Liver transplant | Ischemia-reperfusion injury. Randomised, open-label. 24 participants.
Overview
- Trial Therapeutic Area
- Gastroenterology
- Trial Disease
- Liver transplant | Ischemia-reperfusion injury
- Trial Stage
- Phase I/II
Key dates
- Initial CTIS Submission Date
- 07-11-2023
- First CTIS Authorization Date
- 13-03-2024
Trial design
Randomised, open-label Phase I/II trial across 1 site in Italy.
- Randomised
- Yes
- Open Label
- Yes
- Target Sample Size
- 24
Recruitment
- Planned Sample Size
- 24
- Recruitment Window Months
- 18
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 24
Italy
- Earliest CTIS Part Ii Submission Date
- 08-03-2024
- Latest Decision Or Authorization Date
- 04-08-2025
- Processing Time Days
- 514
- Number Of Sites
- 1
- Number Of Participants
- 24
Sites
- Site Name
- IRCCS Azienda Ospedaliero Universitaria di Bologna - Policlinico S. Orsola-Malpighi
- Department Name
- Department of Medical and Surgical Sciences
- Principal Investigator Name
- Matteo Ravaioli
- Principal Investigator Email
- matteo.ravaioli6@unibo.it
- Contact Person Name
- Matteo Ravaioli
- Contact Person Email
- matteo.ravaioli6@unibo.it
Sponsor
Primary sponsor
- Full Name
- Mimetech S.r.l.
- Organisation Type
- Industry
- Country Of Registered Address
- Italy
Related trials
Other published trials that may interest you.